MSMylène Soudani

Mylène Soudani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mylène Soudani has a total of 31 co-authors. Here are the top co-authors by number of shared publications:

  • Roger Marti

    Institute of Chemical Technology, Haute École d’Ingénierie et d’Architecture Fribourg

    2 shared publications
  • Antony Crisp

    Research School of Chemistry Institute of Advanced Studies The Australian National University Canberra, ACT 2601 Australia

    1 shared publication
  • Arian Bajramaj

    Institute of Chemical Technology, Haute École d’Ingénierie et d’Architecture Fribourg

    1 shared publication
  • Arian Bajramaj

    Institute of Chemical Technology, Haute école d'Ingénierie et d'Architecture Fribourg HES‐SO University of Applied Sciences and Arts Western Switzerland Fribourg Switzerland

    1 shared publication
  • Arunachalam Piramanayagam

    3xper Innoventure Labs Limited, Ticel Bio Park (Phase-2), 7th floor Taramani, Chennai, Tamil Nadu 600113, India

    1 shared publication
  • Béchir Zitouni

    RDP Pharma AG/Valdospan GmbH, Technopark 1D, Tulln an der Donau 3430, Austria

    1 shared publication

Latest Publications

  • Open Access

    Development of a Four-Step Scalable Synthesis for the Alkyl-lysophospholipids ( S )- and ( R )-Edelfosine

    by Mylène Soudani, Cheng-Hao Chang, Yu Fa Wang, Béchir Zitouni, Noel Riedl, Arian Bajramaj, Nika Podlesnik, Ivana Mickovic, Maithrayan Velliangiri, Kaushik Gurusankaran, et al.

    The synthetic alkyl-lysophospholipid (ALP) Edelfosine has garnered attention due to its potent in vivo activity, oral administration route, and synergistic effects with other therapies. Its development as a preclinical candidate, however, is constrained by challenges associated with the economical, large-scale preparation of the enantiopure compound. Herein, we describe the development of a novel synthetic route that provides enantiopure (S)-Edelfosine in a scalable manner, amenable to industrial implementation. Through several iterations, we achieve synthetic improvements via a more convergent assembly of the substituted glycerol portion of the title compounds. By exploiting a chiral benzylglycidyl ether as the key synthon, we demonstrate the successful four-step, formal, and total syntheses of (S)- and (R)-Edelfosine respectively─the shortest demonstrably scalable routes of their kind. Finally, we establish phenyl trimethylammonium iodide as a suitable green alternative to carcinogenic iodomethane in this context. Our streamlined chiral pool approach thus furnishes a significant improvement in the synthetic accessibility of optically pure Edelfosine and paves the way for the parallel development of both medicinally relevant ALP enantiomers.

  • Open Access

    Micellar Suzuki–Miyaura Reaction With Xylose Acetal Cosolvents: A Life Cycle Assessment Approach

    by Arian Bajramaj, Lara Amini, Mylène Soudani, Justine Horner, Esaïe Reusser, Michael U. Luescher, Fabrice Gallou, Roger Marti

    The use of green solvents is a key element in making chemical processes more sustainable. In this work, three biobased solvents, diformyl xylose (DFX), dipropyl xylose (DPX), and n ‐butyl tetrahydrofurfuryl ether (Solvinol), were tested as cosolvents in the Suzuki–Miyaura reaction using micellar catalysis in water (TPGS‐750‐M system). 2% DPX gave > 99% conversion and 86% yield, while 2% DFX reached 86% conversion and 82% yield. Solvinol required 15% loading to give similar results. DFX was easily removed in the aqueous phase upon work‐up, while DPX and Solvinol were more difficult to remove due to their poor water solubility and high boiling points. These results demonstrate the potential of biomass‐derived solvents as green alternatives to classical organic solvents. The overall environmental efficiency of the various processes was assessed via our internal methodology. Their efficiency at low loadings supports their use in more sustainable and environmentally friendly processes.


  • Open Access

    Degradation of Dioxins and DBF in Urban Soil Microcosms from Lausanne (Switzerland): Functional Performance of Indigenous Bacterial Strains

    by Rita Di Martino, Mylène Soudani, Patrik Castiglioni, Camille Rime, Yannick Gillioz, Loïc Sartori, Tatiana Proust, Flavio Neves Dos Santos, Fiorella Lucarini, Davide Staedler

    Urban soils are often affected by long-term deposition of persistent organic pollutants, including polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs). This study evaluated the biodegradation potential of indigenous bacterial strains isolated from chronically contaminated soils in Lausanne, Switzerland. Using selective enrichment techniques, five strains were isolated, with no biosafety concerns for human health and environmental applications. These isolates were screened for their ability to degrade dibenzofuran (DBF) and 2,7-dichlorodibenzo-p-dioxin (2,7-DD) under mineral medium conditions. A simplified two-strain consortium (Acinetobacter bohemicus and Bacillus velezensis) and a broader five-strain co-culture were then applied to real soil microcosms over a 24-week period. This work provides the first experimental evidence that A. bohemicus and B. velezensis can degrade DBF and 2,7-DD under controlled conditions. Dioxin concentrations were monitored at 4, 8, and 24 weeks using a Gas Chromatography Mass Spectrometry (GC-MS). In laboratory conditions, co-cultures showed enhanced degradation compared to individual strains, likely due to metabolic complementarity. In soil, the simplified two-strain consortium performed better at dioxin degradation, especially at earlier time points. Although no statistically significant reductions were observed due to high variability and limited sample size, consistent trends emerged, particularly at the most contaminated site. These findings support the relevance of testing bioremediation strategies under realistic environmental conditions.